Acpio
pioglitazone hydrochloride
Acpio is a Prescription medicine
Main Indication
Treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise:
- as monotherapy;
- as dual therapy to improve glycaemic control
- - in combination with metformin or sulfonylurea
- - in combination with insulin;
- as triple therapy to improve glycaemic control, in combination with metformin and sulfonylurea.
Therapeutic Area
Endocrinology
Sponsor:
Aspen Australia
|
Medical Queries:
02 8436 8300
Acpio is available in these strengths:
- ACPIO 15 pioglitazone (as hydrochloride) 15 mg tablet blister pack
- ACPIO 30 pioglitazone (as hydrochloride) 30 mg tablet blister pack
- ACPIO 45 pioglitazone (as hydrochloride) 45 mg tablet blister pack
